BCA protein assay kit (Pierce, Rockford, IL) was used to measure protein concentrations as described in a previous report [36].
Since the pharmacodynamics are unclear, clinicians should select dosages that would be anticipated to produce adequate concentrations, as described by successful therapeutic studies, throughout the dosage interval.
Synthetic complete (SC) medium contained 0.17% yeast nitrogen base without amino acids and (NH4 2SO4 (MP Biomedicals), 0.5% (NH4 2SO4, all twenty amino acids (Sigma) at concentrations as described (Burke et al., 2000) and 2% of glucose.
Trace elements were present in concentrations as described previously [9].
Samples were then processed for measurement of soluble PAMP concentrations as described below.
VWF-antigen and VWF-propeptide antigen levels were determined and values were converted into molar concentrations as described [11], [17], [18].
From day four onward, Fibroblast growth factor 4 (FGF4) (R&D systems), and Retinoic acid (RA) (Sigma) were added in different combinations and concentrations as described.
Erythrocytes infected with B. divergens were cultured in 24-well plates in triplicates for 72 h in the presence or absence of FR at different concentrations as described above.
Based on our knowledge that Rv3802 is an α/β-hydrolase fold with TE activity, and the structure of THL, we investigated the ability of THL to inhibit recombinant Rv3802 and found it to inhibit at nanomolar concentrations, as described.
Western blot analysis was performed using conditioned medium from thyroid cancer cells (equal protein concentrations) as described in the previous section using MMP-2 and MMP-9 (Cell Signaling Technology Inc., Danvers, MA) antibodies.
The pellet was treated for purification of recombinant Gp63 protein by urea gradient method using 2 M, 4 M and 8 M urea concentrations as described by Sukumaran et al[36].
